Skip to main content
High RiskFDAfda-F-0669-2023UNDECLARED ALLERGEN

Perilla Leaves in Soybean Paste distributed in un-labeled plastic containers 12oz. Containers were then labeled at H-mart, G-mart, or M2...

Category
Units Affected
12
Recall Date
February 23, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0669-2023.

Perilla Leaves in Soybean Paste was recalled due to undeclared Soybean, Wheat, Fish (Anchovy, Big Eye Herring), and Shrimp.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0669-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Lemonland Food Corp or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0669-2023.

Lemonland Food Corp

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Lemonland Food Corp Recall FAQ

Lemonland Food Corp is the subject of a food safety report: Perilla Leaves in Soybean Paste distributed in un-labeled plastic containers 12oz. Containers were then labeled at H-mart, G-mart, or M2.... The notice was published on February 23, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 12 units are potentially affected.